‘CBD’
What are the Harms of CBD Use? Making Sense of the FDA’s Recent Warning
Dec. 2, 2019—In late November 2019, the federal Food and Drug Administration (FDA) warned the public about consuming cannabidiol (CBD). See FDA, What You Need to Know About CBD. It appears the FDA issued the warning because of booming demand for CBD products. From the FDA’s Announcement: “You may have noticed that cannabidiol (CBD) seems to be...
NYT piece on popularity of CBD
Feb. 26, 2019—Roni Caryn Rabin has a new piece in the New York Times discussing what’s behind the newfound popularity of CBD: CBD is Everywhere, but Scientists Still Don’t Know Much About It. As the title of the linked piece suggests, demand for CBD is booming, driven in large part by the belief that the substance can be used...
New Congressional Farm Bill Legalizes Some Marijuana
Dec. 13, 2018—[Updated 12/21 10:45 am: As expected, President Trump signed the Farm Bill into law on Dec. 20. The Commissioner of the FDA also issued a notable statement on the Bill (h/t to Doug Berman). The Commissioner emphasizes the points I make below regarding the ongoing limitations imposed by the FDCA on the use of CBD...
Is CBD Legal Under Federal Law?
Sep. 28, 2018—[Update 12/21 10:45 am: Readers should note that the 2018 Farm Bill has important ramifications of the legality of CBD under federal law. I discuss the Farm Bill and its implications for CBD in this post here. In a nutshell, the Farm Bill makes it legal to possess, manufacture, and distribute CBD extracted from all cannabis plants...
Only One State Has Not Yet Legalized Marijuana in Some Form . . .
Jul. 16, 2018—While updating some of the charts and figures in my book, I discovered that, since early May, 2018, only one state in the nation has not yet legalized marijuana in some form for at least medical purposes. I won’t keep you waiting: it’s Idaho. At the start of the year, Idaho had some company. Kansas...
Caveat Emptor: Are Marijuana Labels Accurate?
Nov. 15, 2017—As discussed in the book, many legalization states have adopted detailed labeling requirements for marijuana products (see pages 456-462). Among other things, suppliers must clearly indicate the quantity of THC and CBD contained in packages of marijuana. Labeling requirements like these are designed to inform consumers and thereby help them make better consumption choices. To...
The Odd Legal Status of CBD under Federal Law
Oct. 18, 2017—As discussed in Chapter 4 of the book, much of the controversy surrounding marijuana’s purported benefits and harms has stemmed from THC, the psychoactive cannabinoid commonly found in the cannabis plant. However, another non-psychoactive cannabinoid, cannabidiol (CBD), has been drawing increasing interest, because it purportedly generates its own distinct medical benefits (e.g., in calming seizures) while producing none...
Iowa Officials Urged Not to Permit Importation of CBD from Minnesota
Sep. 12, 2017—The Iowa Attorney General’s office just advised the state health department not to authorize two Minnesota medical marijuana dispensaries to supply medical marijuana to Iowa residents. If heeded, the advice would nullify a novel provision of Iowa’s nascent medical marijuana program. The provision, adopted as part of a package of reforms in May 2017, calls...
Interesting Opportunity to Try to Shape the WHO’s Scheduling of CBD (and Possibly Domestic Law Too)
Aug. 23, 2017—The World Health Organization (WHO) is apparently reviewing the scheduling of Cannabidiol (CBD) and 16 other drugs under the 1971 Convention on Psychotropic Substances. Prior to a meeting of the relevant WHO committee in early November, the WHO has asked member states (including the U.S.) for input. The Food and Drug Administration (FDA) is responsible...